Endothelin-1 and heme oxygenase-1 as modulators of sinusoidal tone in the stress-exposed rat liver

Hepatology. 2002 Dec;36(6):1453-65. doi: 10.1053/jhep.2002.36934.

Abstract

Heme oxygenase (HO)-1 is up-regulated after ischemia/reperfusion and contributes to maintenance of hepatic perfusion and integrity. Blockade of HO-1 leads to an increased portal pressor response in the stress-exposed liver. We tested whether the increase in portal pressure reflects unmasking of a concomitant up-regulation of the vasoconstrictor endothelin (ET)-1. Hemorrhagic shock induced messenger RNAs encoding HO-1 (16-fold) and ET-1 (9-fold) with a similar time course in the liver. At maximum induction of both mediators, rats received either vehicle or the endothelin ET(A/B) antagonist bosentan (10 mg/kg intravenously). Subsequently, the HO pathway was blocked in all animals by tin-protoporphyrin (SnPP)-IX (50 micromol/kg intravenously). Portal and sinusoidal hemodynamics were measured using microflow probes and intravital microscopy, respectively. Blockade of the HO pathway led to a significant increase in portal resistance (sham/SnPP-IX, 0.17 +/- 0.046 mm Hg. min. mL(-1); shock/vehicle/SnPP-IX, 0.57 +/- 0.148 mm Hg. min. mL(-1); P <.05) and a decrease in sinusoids conducting flow (shock/vehicle/SnPP-IX: baseline, 28.3 +/- 0.85 sinusoids/mm; 10 minutes after SnPP-IX, 23.1 +/- 1.09 sinusoids/mm; P <.05). Intravital microscopy showed narrowing of failing sinusoids colocalizing with stellate cells after blockade of the HO pathway. Blockade of ET(A/B) receptors attenuated the increase in portal resistance (shock/bosentan/SnPP-IX, 0.29 +/- 0.051 mm Hg. min. mL(-1)) and prevented sinusoidal perfusion failure (shock/bosentan/SnPP-IX: baseline, 28.2 +/- 0.97 sinusoids/mm; 10 minutes after SnPP-IX, 28.8 +/- 1.18 sinusoids/mm) as well as sinusoidal narrowing. In conclusion, a functional interaction of the up-regulated vasodilatory HO system and the vasoconstrictor ET-1 on the sinusoidal level exists under stress conditions. Both mediator systems affect sinusoidal diameter via direct action on hepatic stellate cells in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Bosentan
  • Dose-Response Relationship, Drug
  • Endothelin Receptor Antagonists
  • Endothelin-1 / genetics
  • Endothelin-1 / metabolism*
  • Enzyme Inhibitors / pharmacology*
  • Gene Expression / physiology
  • Heme Oxygenase (Decyclizing) / antagonists & inhibitors
  • Heme Oxygenase (Decyclizing) / genetics
  • Heme Oxygenase (Decyclizing) / metabolism*
  • Heme Oxygenase-1
  • Liver / metabolism*
  • Liver Circulation / drug effects
  • Liver Circulation / physiology
  • Male
  • Metalloporphyrins / pharmacology
  • Molsidomine / pharmacology
  • Nitric Oxide Donors / pharmacology
  • Portal Vein / physiology
  • Protoporphyrins / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Endothelin / metabolism
  • Resuscitation
  • Shock, Hemorrhagic / metabolism*
  • Stress, Physiological / metabolism*
  • Sulfonamides / pharmacology

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Enzyme Inhibitors
  • Metalloporphyrins
  • Nitric Oxide Donors
  • Protoporphyrins
  • Receptors, Endothelin
  • Sulfonamides
  • Molsidomine
  • tin protoporphyrin IX
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
  • Bosentan